Integral Derivatives’s Rite Aid Corporation RAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$218K Sell
6,490
-3,085
-32% -$122K 0.01% 599
2017
Q4
$377K Buy
9,575
+5,355
+127% +$191K 0.01% 802
2017
Q3
$165K Sell
4,220
-445
-10% -$21.1K ﹤0.01% 1043
2017
Q2
$275K Buy
4,665
+3,825
+455% +$289K 0.01% 890
2017
Q1
$71K Sell
840
-1,730
-67% -$208K ﹤0.01% 1094
2016
Q4
$424K Sell
2,570
-140
-5% -$21.2K 0.01% 776
2016
Q3
$417K Buy
2,710
+145
+6% +$21.6K 0.01% 688
2016
Q2
$384K Sell
2,565
-2,575
-50% -$406K 0.01% 677
2016
Q1
$838K Buy
5,140
+435
+9% +$68.6K 0.03% 402
2015
Q4
$738K Buy
4,705
+1,910
+68% +$283K 0.02% 560
2015
Q3
$339K Buy
2,795
+495
+22% +$82.5K 0.01% 821
2015
Q2
$384K Sell
2,300
-3,660
-61% -$614K 0.01% 794
2015
Q1
$1.04M Sell
5,960
-14,615
-71% -$2.28M 0.02% 504
2014
Q4
$3.09M Buy
20,575
+7,575
+58% +$841K 0.05% 297
2014
Q3
$1.26M Buy
13,000
+620
+5% +$80K 0.02% 623
2014
Q2
$1.77M Sell
12,380
-2,625
-17% -$387K 0.03% 476
2014
Q1
$1.88M Sell
15,005
-5,965
-28% -$727K 0.04% 434
2013
Q4
$2.12M Buy
+20,970
New +$2.23M 0.03% 467

Other funds holding RAD

Integral Derivatives's RAD Position: Q4 2017 in Review

Integral Derivatives sold out of Rite Aid Corporation (RAD) in Q4 2017, closing a stake of 1,475 shares — an estimated $52.7K sold.

Integral Derivatives first reported a position in RAD in Q1 2015 and held it in 5 quarters. The position peaked at $269K in Q2 2015. 349 funds tracked by Wall St. Rank hold RAD as of Q4 2017.

  • Integral Derivatives reported no remaining Rite Aid Corporation position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 1,475 Rite Aid Corporation shares in Q4 2017, an estimated $52.7K.
  • Integral Derivatives first reported a position in Rite Aid Corporation in Q1 2015 and held it in 5 quarters.
  • Integral Derivatives's Rite Aid Corporation position peaked at $269K in Q2 2015.
  • 349 funds tracked by Wall St. Rank held Rite Aid Corporation as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.